CLINICAL TRIALS PROFILE FOR SETIPIPRANT
✉ Email this page to a colleague
Clinical Trials for Setipiprant
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT01225315 ↗ | Clinical Study to Explore the Efficacy of ACT-129968 in Patients With Partly Controlled Asthma | Completed | Actelion | Phase 2 | This study will assess the efficacy and safety of ACT-129968 in subjects with partly controlled asthma on reliever therapy only. |
NCT01225315 ↗ | Clinical Study to Explore the Efficacy of ACT-129968 in Patients With Partly Controlled Asthma | Completed | Idorsia Pharmaceuticals Ltd. | Phase 2 | This study will assess the efficacy and safety of ACT-129968 in subjects with partly controlled asthma on reliever therapy only. |
NCT01484119 ↗ | Efficacy, Safety, and Tolerability Study of ACT-129968 in Patients With Seasonal Allergic Rhinitis | Completed | Actelion | Phase 3 | This study will assess the efficacy and safety of ACT-129968 in adolescent, adult and elderly patients with seasonal allergic rhinitis, due to mountain cedar pollen. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for Setipiprant
Condition Name
Clinical Trial Locations for Setipiprant
Trials by Country
Clinical Trial Progress for Setipiprant
Clinical Trial Phase
Clinical Trial Sponsors for Setipiprant
Sponsor Name